
Relidoce 80mg Injection
Marketer
Reliance Formulation Pvt Ltd
Salt Composition
Docetaxel (80mg)
Overview Relidoce 80mg Injection
Oncaspar 80mg Injection is a chemotherapy agent indicated for breast, non-small cell lung, prostate, and head and neck cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined individually by your physician, depending on your specific cancer and may be adjusted. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling (edema), infections, appetite loss, myalgia, nail problems, pain, and fatigue. Your doctor might prescribe additional medications to mitigate these effects. Report immediately any unusual bruising/bleeding, sore throat, mouth sores, or fever. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are mandatory. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, to your doctor. Significant drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout the treatment period.
Uses of Relidoce 80mg Injection
Cancers affecting the breast, lungs (non-small cell), prostate, and head/neck.
Major Benefits of Relidoce 80mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relidoce 80mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Relidoce 80mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Relidoce 80mg Injection works:
Oncaspar 80mg Injection is a cancer treatment that disrupts microtubule networks, essential for cancer cell division and proliferation. This action inhibits tumor growth, leading to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Relidoce 80mg Injection is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Relidoce 80mg Injection during pregnancy poses a confirmed risk to the fetus, rendering its use unsafe. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Relidoce 80mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingCONSULT YOUR DOCTOR
Relidoce 80mg Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Relidoce 80mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Caution is advised when administering Relidoce 80mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Relidoce 80mg Injection :
NA
Facts to Know About Relidoce 80mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
